Atlas Trials

Obesity, Insulin Resistance, and PASC: Persistent SARS-CoV-2

Clinical trial NCT05833217 · RECRUITING

Trial details

NCT number
NCT05833217
Sponsor
Stanford University
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Long COVIDInsulin ResistanceInsulin Sensitivity
Start date
2023-06-06
Primary completion
2025-05-02
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.